| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Revenue | — | — |
| Cost of Revenue | $9.0B | $7.3B |
| Gross Profit | $7.4B | $6.7B |
| R&D Expense | $1.0B | $0.8B |
| SG&A Expense | — | — |
| Operating Income | $0.0B | $0.9B |
| Net Income | $-0.4B | $0.2B |
| EPS (Basic) | $-1.75 | $0.24 |
| EPS (Diluted) | $-1.75 | $0.24 |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Total Assets | $29.3B | $24.5B |
| Current Assets | $4.8B | $4.3B |
| Cash & Equivalents | $1.8B | $1.5B |
| Total Liabilities | $19.6B | $13.2B |
| Current Liabilities | $5.0B | $4.6B |
| Stockholders' Equity | $9.0B | $9.3B |
| Metric | FY 2025↕ | FY 2024↕ |
|---|---|---|
| Operating Cash Flow | $1.2B | $1.6B |
| Investing Cash Flow | $-3.5B | $-0.8B |
| Capital Expenditures | $0.1B | $0.1B |
| Financing Cash Flow | $2.4B | $-0.5B |